Bajaj Healthcare rises on acquiring Genrx Pharmaceuticals

08 Apr 2025 Evaluate

Bajaj Healthcare is currently trading at Rs. 575.00, up by 5.05 points or 0.89% from its previous closing of Rs. 569.95 on the BSE.

The scrip opened at Rs. 589.10 and has touched a high and low of Rs. 598.55 and Rs. 571.00 respectively. So far 18589 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 744.90 on 19-Mar-2025 and a 52 week low of Rs. 265.00 on 04-Jun-2024.

Last one week high and low of the scrip stood at Rs. 701.00 and Rs. 507.65 respectively. The current market cap of the company is Rs. 1819.20 crore.

The promoters holding in the company stood at 59.19%, while Institutions and Non-Institutions held 3.37% and 37.45% respectively.

Bajaj Healthcare has successfully acquired Genrx Pharmaceuticals (in Liquidation) as a going concern, as per the Sale Certificate dated April 4, 2025, issued by the Official Liquidator. The acquisition, valued at Rs 10.85 crore through a cash consideration, involves 100% control of the target entity.

Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.

Bajaj Healthcare Share Price

412.65 -4.15 (-1.00%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×